Exendin-4 and sitagliptin protect kidney from ischemia-reperfusion injury through suppressing oxidative stress and inflammatory reaction
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Background: This study tested the hypothesis that exendin-4 and sitagliptin can effectively protect kidney from acute ischemia-reperfusion (IR) injury. Methods: Adult SD-rats (n = 48) equally divided into group 1 (sham control), group 2 (IR injury), group 3 [IR + sitagliptin 600 mg/kg at post-IR 1, 24, 48 hr)], and group 4 [IR + exendin-4 10 μm/kg at 1 hr after procedure] were sacrificed after 24 and 72 hrs (n = 6 at each time from each group) following clamping of bilateral renal pedicles for 60 minutes (groups 2–4). Results: Serum creatinine level and urine protein to creatinine ratio were highest in group 2 and lowest in group 1 (all p < 0.001) without notable differences between groups 3 and 4. Kidney injury score, expressions of inflammatory biomarkers at mRNA (MMP-9, TNF-α, IL-1β, PAI-1), protein (TNF-α, NF-κB and VCAM-1), and cellular (CD68+) levels in injured kidneys at 24 and 72 hr showed an identical pattern compared to that of creatinine level in all groups (all p < 0.0001). Expressions of oxidized protein, reactive oxygen species (NOX-1, NOX-2), apoptosis (Bax, caspase-3 and PARP), and DNA damage marker (γH2AX+) of IR kidney at 24 and 72 hrs exhibited a pattern similar to that of inflammatory mediators among all groups (all p < 0.01). Renal expression of glucagon-like peptide-1 receptor, and anti-oxidant biomarkers at cellular (GPx, GR) and protein (NQO-1, HO-1, GPx) levels at 24 and 72 hr were lowest in group 1, significantly lower in group 2 than in groups 3 and 4 (all p < 0.01). Conclusion: Exendin-4 and sitagliptin provided significant protection for the kidneys against acute IR injury.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Hattori, Y., Jojima, T., Tomizawa, A., Satoh, H., Hattori, S., Kasai, K., & Hayashi, T. (2010) · Diabetologia · doi:10.1007/s00125-010-1831-8 · Cited by 183 · cited 4×
“Beside their well-known roles as hypoglycemic agents, GLP-1 analogues (including exendin-4) have been reported to possess both antioxidative properties [29-31] and anti-inflammatory [31-33] properties.”
BackgroundResultInfluentialRetractedGöke, R., Larsen, P. J., Mikkelsen, J. D., & Sheikh, S. P. (1995) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1995.tb00650.x · Cited by 474 · cited 1×
“, GLP1R) in the central nervous system and the peripheral autonomic nervous system has been extensively investigated in previous studies [40-45], the expression of GLP-1R in renal parenchyma has not been reported.”
BackgroundVahl, T. P., Tauchi, M., Durler, T. S., Elfers, E. E., Fernandes, T. M., Bitner, R. D., Ellis, K. S., Woods, S. C., Seeley, R. J., Herman, J. P., et al. (2007) · Endocrinology · doi:10.1210/en.2006-0153 · Cited by 318 · cited 1×
“, GLP1R) in the central nervous system and the peripheral autonomic nervous system has been extensively investigated in previous studies [40-45], the expression of GLP-1R in renal parenchyma has not been reported.”
BackgroundKim, S., Moon, M., & Park, S. (2009) · Journal of Endocrinology · doi:10.1677/joe-09-0132 · Cited by 263 · cited 4×
“Beside their well-known roles as hypoglycemic agents, GLP-1 analogues (including exendin-4) have been reported to possess both antioxidative properties [29-31] and anti-inflammatory [31-33] properties.”
BackgroundResultInfluentialHamilton, A., & Hölscher, C. (2009) · NeuroReport · doi:10.1097/wnr.0b013e32832fbf14 · Cited by 227 · cited 1×
“prolonged or even transient IR injury [13,22,28].”
Glucagon-like peptide-1 inhibits LPS-induced IL-1β production in cultured rat astrocytes
Iwai, T., Ito, S., Tanimitsu, K., Udagawa, S., & Oka, J.-I. (2006) · Neuroscience Research · doi:10.1016/j.neures.2006.04.008 · Cited by 207 · cited 4×
“Beside their well-known roles as hypoglycemic agents, GLP-1 analogues (including exendin-4) have been reported to possess both antioxidative properties [29-31] and anti-inflammatory [31-33] properties.”
InfluentialLong-term effects of acute ischemia and reperfusion injury
Gueler, F., Gwinner, W., Schwarz, A., & Haller, H. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.761_11.x · Cited by 189 · cited 1×
“; licensee BioMed Central L Commons Attribution License (http://creativec reproduction in any medium, provided the or etiology of AKI is multifactorial [1-12].”
Background
Cited by
Anti-Inflammatory Effects of GLP-1-Based Therapies beyond Glucose Control
Lee, Y.-S., & Jun, H.-S. (2016) · Mediators of Inflammation · doi:10.1155/2016/3094642 · Cited by 530
“In addition, after ischemia-reperfusion injury, the expression of proinflammatory cytokines, NF-κB and ICAM-1, as well as macrophage infiltration in the kidney was significantly decreased by exendin-4 (10 μg/kg) or sitagliptin (600mg/kg) treatment [109].”
BackgroundGLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes
Muskiet, M. H. A., Tonneijck, L., Smits, M. M., van Baar, M. J. B., Kramer, M. H. H., Hoorn, E. J., Joles, J. A., & van Raalte, D. H. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.123 · Cited by 407
Athauda, D., & Foltynie, T. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.01.013 · Cited by 383
Pleiotropic Effects of GLP-1 and Analogs on Cell Signaling, Metabolism, and Function
Rowlands, J., Heng, J., Newsholme, P., & Carlessi, R. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00672 · Cited by 302
“Activation of the GLP-1R/cAMP/PKA pathway is also crucial in renal protection, with studies in a range of rodent models reporting a reduction in renal inflammation, renal fibrosis, and decrease in renal oxidative stress arising from the toxic milieu induced in metabolic syndrome (158, 161, 166, 177, 178).”
BackgroundIncretin drugs in diabetic kidney disease: biological mechanisms and clinical evidence
Alicic, R. Z., Cox, E. J., Neumiller, J. J., & Tuttle, K. R. (2021) · Nature Reviews Nephrology · doi:10.1038/s41581-020-00367-2 · Cited by 193
Metadata
- Authors
- Chen, Y.-T., Tsai, T.-H., Yang, C.-C., Sun, C.-K., Chang, L.-T., Chen, H.-H., Chang, C.-L., Sung, P.-H., Zhen, Y.-Y., Leu, S., Chang, H.-W., Chen, Y.-L., & Yip, H.-K.
- Venue
- Journal of Translational Medicine
- Published
- 2013-10-25
- Volume
- 11
- Issue
- 1
- Pages
- 270-270
- ISSN
- 1479-5876 (ISSN-L)
- OpenAlex
- W2115197476
- Cited by
- 109
- References
- 7
- FWCI
- 6.85
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Exendin-4 and sitagliptin protect kidney from ischemia-reperfusion injury through suppressing oxidative stress and inflammatory reaction. https://app.cochat.ai/papers/10.1186/1479-5876-11-270
- The paper
- Chen, Y.-T., Tsai, T.-H., Yang, C.-C., Sun, C.-K., Chang, L.-T., Chen, H.-H., Chang, C.-L., Sung, P.-H., Zhen, Y.-Y., Leu, S., Chang, H.-W., Chen, Y.-L., & Yip, H.-K. (2013). Exendin-4 and sitagliptin protect kidney from ischemia-reperfusion injury through suppressing oxidative stress and inflammatory reaction. Journal of Translational Medicine. https://doi.org/10.1186/1479-5876-11-270
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.